Events

Joshua Zeidner, MD
Director, Clinical Cancer Research Commercial Integration,
Assoc. Chief of Research, Hematology, and
Section Chief, Leukemia Research; Lineberger Comprehensive Cancer Center, University of North Carolina
Assoc. Professor of Medicine, University of North Carolina, Dept. of Medicine, Div. of Hematology

Title: "Incorporating Menin Inhibitors into Frontline Therapy for Older Adults with AML: Light at the End of the Tunnel?"

Hosted by Aaron Viny, MD, Assistant Professor of Medicine, CUIMC.

This event is sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) at Columbia University, established to foster an all-encompassing approach in studying MDS giving us molecular, cellular genetic and epigenetic insights to develop and test innovative therapies.